Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcome

27 Apr 2015

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Hematopoietic Stem Cell Transplantation
Share to Myeloproliferative Neoplasms: Diagnosis and Treatment

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25915806
DOI: 10.1038/bmt.2015.82

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Allogeneic hematopoietic cell transplant for AML: no impact of pre-transplant extramedullary disease on outcomePMID 25915806Read ↗

Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AMLSemantic proximity Read ↗

Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remissionSemantic proximity Read ↗

To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision.Semantic proximity Read ↗

Outcomes of Second Allogeneic Hematopoietic Cell Transplantation for Patients With Acute Myeloid LeukemiaSemantic proximity Read ↗

Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)Semantic proximity Read ↗

MRD in AML: time for redefinition of CR?Semantic proximity Read ↗

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia in older adultsSemantic proximity Read ↗

Allogeneic transplant for FLT3-ITD+ AML: room for improvement.Semantic proximity Read ↗

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers.Semantic proximity Read ↗

Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter surveySemantic proximity Read ↗

Hematopoietic cell transplantation in patients with intermediate and high-risk AML: results from the randomized Study Alliance Leukemia (SAL) AML 2003 trial.Semantic proximity Read ↗

Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.